Shifting the Mindset on Medicine | Panel Discussion | Cicada x Tech23
- Roam Team
- Aug 20, 2024
- 2 min read
Updated: Jul 29
About the Theme:
Shifting the Mindset on Medicine How can emerging deep tech innovations transform our understanding and practice of healthcare?
What's Cicada x Tech23?
Cicada x Tech23 is Australia's biggest celebration of deep tech. The event connects founders with brave ideas about the future to an audience of investors, business leaders and policymakers – inviting everyone support game-changing people and ideas that can revolutionise our world.
Tetratherix (Ali Fathi, Founder & CTO): Nearly 30% of vaccine doses are wasted per year due to their stringent storage requirements and logistical challenges. These issues hinder the effectiveness of treatments and vaccines, particularly in emergency situations like pandemics. Tetratherix aims to address this with its revolutionary biostealth fluid matrix technology. This fully synthetic, biocompatible platform disrupts regenerative medicine and targeted mRNA delivery, offering versatile solutions for multiple unmet clinical needs. Backed by a decade of research and successful trials, Tetratherix’s solution promises improved therapeutic delivery without triggering foreign body reactions. The company’s mission is to positively impact 10 million lives globally within a decade by ensuring widespread, affordable access to its innovative solutions.
Roam Technologies (ShanShan Wang, CEO & Founder) : Millions of people are affected by respiratory illnesses and need medical oxygen to survive. However, existing oxygen therapy relies on bulky, heavy canisters that restrict patient movement. Roam Technologies solves this issue with their portable oxygen concentrator, called JUNO. JUNO is up to 50% smaller than traditional oxygen tanks, and delivers over 1 litre of continuous oxygen flow per minute, meeting the same standards as leading hospital equipment. JUNO also provides 90% pure medical-grade oxygen, ensuring patients get oxygen safely, while meeting the highest clinical FDA and TGA standards. Roam Technologies is committed to transforming oxygen therapies, as JUNO is designed with patient-centred care in mind, offering freedom and mobility anytime, anywhere.
OminiWell (Sylvia Chien, CEO): In 2020 alone, there were an estimated 20 million new cancer cases, resulting in 9.7 million deaths globally. Timely treatment is critical for survival, yet evaluating treatment effectiveness can take 3-9 months. OminiWell tackles this challenge with the ‘BioTwin Chip’, an in vitro cell culture device. This innovative chip swiftly recreates a personalised ‘biological twin’ using a person’s biological elements, forming 3D cell structures within one day. Capable of cultivating cell lines, organoids, and primary tissues, this platform tests efficacy across various cancer types. This tumour-on-a-chip aims to dramatically accelerate treatment prediction, delivering results in just 1-2 weeks. The BioTwin Chip heralds a future of tailored cancer care, promising faster recoveries with fewer side effects.
